These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32205101)

  • 21. Lipid target achievement among patients with very high and high cardiovascular risk in a lipid clinic.
    Barkas F; Liberopoulos EN; Kostapanos MS; Liamis G; Tziallas D; Elisaf M
    Angiology; 2015 Apr; 66(4):346-53. PubMed ID: 24830420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
    ; Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Perrone Filardi P; Riccardi G; Storey RF; Wood D;
    Atherosclerosis; 2011 Jul; 217 Suppl 1():S1-44. PubMed ID: 21723445
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipids, statins and cardiovascular disease.
    Cheifitz R
    Climacteric; 2008 Aug; 11(4):347-8; author reply 348-50. PubMed ID: 18645702
    [No Abstract]   [Full Text] [Related]  

  • 24. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
    Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman M; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D; ;
    Atherosclerosis; 2011 Jul; 217(1):3-46. PubMed ID: 21882396
    [No Abstract]   [Full Text] [Related]  

  • 25. Can the ESC/EAS LDL-cholesterol target in patients with diabetes and high cardiovascular risk be achieved in clinical practice? Results from an ambulatory multidisciplinary diabetes center cohort.
    Vidal-Trécan T; Laloi-Michelin M; Bouché C; Juddoo V; Dillinger JG; Azancot I; Kevorkian JP; Salle L; Feron F; Henry P; Gautier JF; Riveline J
    Diabetes Metab; 2019 Dec; 45(6):592-595. PubMed ID: 29609948
    [No Abstract]   [Full Text] [Related]  

  • 26. Dyslipidaemias: new mechanistic insights and the 2016 ESC Guidelines.
    Lüscher TF
    Eur Heart J; 2016 Oct; 37(39):2963-2965. PubMed ID: 27923852
    [No Abstract]   [Full Text] [Related]  

  • 27. Statins: Are they really all the same?
    Cortese F
    Curr Vasc Pharmacol; 2019; 17(3):211-212. PubMed ID: 30003860
    [No Abstract]   [Full Text] [Related]  

  • 28. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
    Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL
    Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of low-density lipoprotein cholesterol levels in South Africa: the International ChoLesterol management Practice Study (ICLPS).
    Blom DJ; Raal F; Amod A; Naidoo P; Lai YE;
    Cardiovasc J Afr; 2019 Jan/Feb 23; 30(1):15-23. PubMed ID: 30720848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients' quality of life in Greece: The CHALLENGE study.
    Alexopoulos D; Anastasiou-Nana M; Elisaf MS; Liberopoulos E; Rallidis LS; Davos CH; Moulis A; Nikas N; Zacharis E; Vardas P;
    Int J Cardiol; 2016 Aug; 217():183-9. PubMed ID: 27183455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER?
    Banach M; Penson PE
    Cardiovasc Res; 2019 Mar; 115(3):e26-e31. PubMed ID: 30605511
    [No Abstract]   [Full Text] [Related]  

  • 32. 'Ten Commandments' from the 2016 ESC/EAS Guidelines for the management of dyslipidaemias.
    Eur Heart J; 2016 Oct; 37(39):2966. PubMed ID: 27923853
    [No Abstract]   [Full Text] [Related]  

  • 33. Statins.
    Ratchford EV; Martin SS
    Vasc Med; 2017 Oct; 22(5):442-445. PubMed ID: 28803537
    [No Abstract]   [Full Text] [Related]  

  • 34. The new joint EAS/ESC guidelines for the management of dyslipidaemias.
    Catapano AL; Chapman J; Wiklund O; Taskinen MR
    Atherosclerosis; 2011 Jul; 217(1):1. PubMed ID: 21722901
    [No Abstract]   [Full Text] [Related]  

  • 35. Non-HDL cholesterol as a therapeutic goal.
    Brea A; Hernández-Mijares A; Millán J; Ascaso JF; Blasco M; Díaz A; Mantilla T; Pedro-Botet JC; Pintó X
    Clin Investig Arterioscler; 2019 Dec; 31 Suppl 2():28-33. PubMed ID: 31806265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comments on the ESC/EAS guidelines for the management of dyslipidaemias 2011. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology].
    Anguita M; Alegría E; Barrios V; Casasnovas JA; Escobar C; León M; Luengo E; Llisterri JL; Alonso Á; Cequier Á; Comín J; Fernández-Ortiz A; Heras M; Pan M; Worner F
    Rev Esp Cardiol; 2011 Dec; 64(12):1090-5. PubMed ID: 22107831
    [No Abstract]   [Full Text] [Related]  

  • 37. Under-prescription of statins in patients with non-alcoholic fatty liver disease.
    Del Ben M; Baratta F; Polimeni L; Pastori D; Loffredo L; Averna M; Violi F; Angelico F
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):161-167. PubMed ID: 27914698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New guidelines on dyslipidemia management: Comparison of French (HAS) and European (ESC/EAS) guidelines].
    Farnier M
    Presse Med; 2018 Sep; 47(9):769-774. PubMed ID: 30274915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyslipidemia intervention in metabolic syndrome: emphasis on improving lipids and clinical event reduction.
    Lavie CJ; Milani RV; O'Keefe JH
    Am J Med Sci; 2011 May; 341(5):388-93. PubMed ID: 21519201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Standardization of laboratory and lipid profile evaluation: A call for action with a special focus in 2016 ESC/EAS dyslipidaemia guidelines - Full report.
    da Silva PM; Duarte JS; von Hafe P; Gil V; de Oliveira JN; de Sousa G
    Atheroscler Suppl; 2018 Jun; 31():e1-e12. PubMed ID: 29859563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.